NADH regulates the release of calcium from the endoplasmic reticulum by modulation of inositol 1,4,5-trisphosphate receptors (IP3R), accounting for the augmented calcium release of hypoxic cells. We report selective binding of IP3R to GAPDH, whose activity leads to the local generation of NADH to regulate intracellular calcium signaling. This interaction requires cysteines 992 and 995 of IP3R and C150 of GAPDH. Addition of native GAPDH and NAD ؉ to WT IP3R stimulates calcium release, whereas no stimulation occurs with C992S͞995S IP3R that cannot bind GAPDH. Thus, the IP3R͞ GAPDH interaction likely enables cellular energy dynamics to impact calcium signaling. (5) and is thought to inhibit IP 3 R function when cellular ATP levels are decreased (6). In conditions where oxidative respiration is inhibited (e.g., hypoxia), cellular NADH levels are amplified (7). We showed that NADH stimulation of IP 3 R calcium release mediates hypoxic mobilization of calcium (8). In hypoxic PC12 cells and cerebellar Purkinje neurons, rapid increases in internal Ca 2ϩ derived from IP 3 -sensitive stores were demonstrated to be directly regulated by GAPDH-derived NADH. However, it was not clear whether global increases in NADH elicited by GAPDH were responsible for this activity or whether such a signal was localized. In this study we demonstrate that GAPDH physiologically binds IP 3 R and discretely delivers NADH, eliciting calcium release. The GAPDH͞ IP 3 R link is a means whereby cellular energetics can regulate Ca 2ϩ signaling.
NADH regulates the release of calcium from the endoplasmic reticulum by modulation of inositol 1,4,5-trisphosphate receptors (IP3R), accounting for the augmented calcium release of hypoxic cells. We report selective binding of IP3R to GAPDH, whose activity leads to the local generation of NADH to regulate intracellular calcium signaling. This interaction requires cysteines 992 and 995 of IP3R and C150 of GAPDH. Addition of native GAPDH and NAD ؉ to WT IP3R stimulates calcium release, whereas no stimulation occurs with C992S͞995S IP3R that cannot bind GAPDH. Thus, the IP3R͞ GAPDH interaction likely enables cellular energy dynamics to impact calcium signaling.
calcium ͉ hypoxia ͉ metabolism I nositol 1,4,5-trisphosphate (IP 3 ) is a major second messenger molecule that binds to the IP 3 receptor (IP 3 R), releasing intracellular endoplasmic reticulum Ca 2ϩ stores (1, 2) . Whereas the IP 3 R is 2,749 amino acids, the portion responsible for its Ca 2ϩ release activity (IP 3 binding domain and the calcium ion channel) comprises only Ϸ550 amino acids of the entire protein (1, 2) . The large intervening region of IP 3 R contains sites for numerous binding proteins and small molecules that regulate IP 3 release of Ca 2ϩ . Hence, IP 3 R is an integrator protein calibrating intracellular Ca 2ϩ signaling in response to diverse stimuli. Cells need to coordinate signaling with metabolic demands. ATP, the major component of metabolism, has already been demonstrated to regulate IP 3 R. At physiological levels, ATP enhances IP 3 -mediated calcium flux as demonstrated with purified IP 3 R in lipid vesicles (3), lipid bilayers (4), or permeabilized cells (5) and is thought to inhibit IP 3 R function when cellular ATP levels are decreased (6) . In conditions where oxidative respiration is inhibited (e.g., hypoxia), cellular NADH levels are amplified (7) . We showed that NADH stimulation of IP 3 R calcium release mediates hypoxic mobilization of calcium (8) . In hypoxic PC12 cells and cerebellar Purkinje neurons, rapid increases in internal Ca 2ϩ derived from IP 3 -sensitive stores were demonstrated to be directly regulated by GAPDH-derived NADH. However, it was not clear whether global increases in NADH elicited by GAPDH were responsible for this activity or whether such a signal was localized. In this study we demonstrate that GAPDH physiologically binds IP 3 R and discretely delivers NADH, eliciting calcium release. The GAPDH͞ IP 3 R link is a means whereby cellular energetics can regulate Ca 2ϩ signaling.
Materials and Methods
IP3R and GAPDH Mutagenesis. Site-directed IP 3 R mutations were introduced by using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) on a rat His-tagged WT IP 3 R and confirmed by sequencing. C150S GAPDH construct was generously provided by Akira Sawa and Makoto Hara (The Johns Hopkins University School of Medicine).
Culture of Cells. Human embryonic kidney 293 cells and COS-7 cells (passage numbers 5-25) were cultured as described in refs. 9 and 10.
Yeast Two-Hybrid System. Experiments were performed by using the Matchmaker 3 yeast two-hybrid system (Clontech) with all IP 3 R fragments cloned into the pGBKT7-binding domain vector by using EcoRI͞SalI restriction sites and all GAPDH fragments cloned into the pGADT7 vector by using EcoRI͞XhoI restriction sites. Expression was confirmed by Western blotting by using antibodies from Clontech. Positive transformants were selected on -Leu͞-Trp͞-Ade͞-His plates containing 5-bromo-4-chloro-3-indolyl-␣-Dgalactopyranoside.
Calcium Release Measurements. Calcium release through recombinant type I (SIIϩ) IP 3 R or mutant IP 3 R was measured as described in ref. 10 . When GAPDH was added, cofactors were added according to Sigma's specifications for GAPDH activity.
Heparin Pull-Down. Purified IP 3 R (50 nM) and GAPDH (50 nM) were incubated in lysis buffer (150 mM NaCl͞50 mM Tris, pH 7.8͞1% Triton X-100͞1 mM EDTA) with a 50-l bed volume of heparin beads for 1 h at 4°C. Samples were then washed 10 times with 20 volumes of lysis buffer and prepared for Western analysis.
Coimmunoprecpitation. Coimmunoprecipitation of ␣-myc-and ␣-histidine-tagged antibodies was performed as described in ref. 9 .
Lipid Vesicle Assay Containing IP3R Purified Rat Cerebellum. This assay was performed as described in ref. 6 except the uptake buffer contained 200 nM Ca 2ϩ in addition to the 45 Ca 2ϩ . When GAPDH was added to this assay, cofactors were added according to Sigma's specifications for GAPDH activity.
Antibodies and Reagents. Plasmids were obtained from the following sources: Matchmaker 3 yeast two-hybrid kit and MYC-tagged vector cDNA were from Clontech; anti-His antibody, anti-MYC antibody, purified GAPDH, NAD ϩ , NADH, purified glyceraldehyde-3-phosphate and IP 3 were from Sigma; polyclonal anti-IP 3 R was generated in our laboratory; and monoclonal GAPDH antibody was from Chemicon.
Results
We performed yeast two-hybrid analysis for the entire rat type 1 IP 3 R as described in ref. 11 . Using a bait comprising amino acids 923-1581, we identify numerous clones coding for GAPDH (Fig.  1A) . We have mapped the portion of GAPDH that binds IP 3 R to 11 amino acids (145-155) including the critical catalytic cysteine-150 of GAPDH (Fig. 1B) . Mutation of this cysteine to serine abolishes binding. We have confirmed the interactions of GAPDH and IP 3 R by demonstrating direct in vitro binding of the two purified proteins as well as coimmunoprecipitation in intact cells (Fig. 1C) .
Conversely, we mapped the sequence of IP 3 R that binds GAPDH to amino acids 981-1000 (Fig. 1D) . This sequence con- tains two cysteines (C992 and C995) which could confer a disulfide linkage with GAPDH C150. To test this possibility, we mutated these two cysteines in full length IP 3 R (Fig. 1E) . Mutation of either C992 or C995 to serine diminishes binding, whereas mutation of both abolishes binding.
The binding of GAPDH to IP 3 R is precise and physiological, suggesting that GAPDH could synthesize NADH close to the channel, thus regulating discrete Ca 2ϩ signaling. To examine this possibility, we monitored calcium flux of purified IP 3 R protein reconstituted into lipid vesicles as described in ref. 6 . Although GAPDH alone is ineffective, the combination of NAD ϩ and GAPDH doubles the activity of IP 3 R in response to IP 3 ( Fig. 2A) . Half-maximal augmentation of Ca 2ϩ flux occurs at Ϸ10 nM GAPDH, which may reflect its binding affinity for IP 3 R. NAD ϩ (100 M) alone produces only a small increase in Ca 2ϩ release. In our earlier study, 50 M NADH produced half-maximal increases in calcium flux, whereas NAD ϩ had negligible effects at 100 M (8). The ability of 10 nM GAPDH with 100 M NAD ϩ to elicit the same increase in calcium flux as 50 M NADH is a 5,000-fold amplification and likely reflects the catalytic activity of the enzyme.
We next examined crude microsomal membrane preparations from COS-7 cells transfected with either WT IP 3 R or C992S͞ C995S IP 3 R that cannot bind GAPDH (Fig. 2 B and C) . The addition of GAPDH and NAD ϩ to WT IP 3 R causes maximal vesicular Ca 2ϩ release at submaximal IP 3 concentrations, whereas GAPDH alone has no effect. In contrast with the purified vesicle data, NAD ϩ alone causes significant calcium release. This result could reflect endogenous GAPDH associated with the IP 3 R. Consistent with this hypothesis, C992S͞C995S IP 3 R does not respond to the addition of NAD ϩ ͞GAPDH but remains able to release calcium in the presence of NADH. This finding establishes that binding of GAPDH to IP 3 R is required for the enzyme to synthesize NADH to alter local IP 3 R calcium flux.
Discussion
The main finding of this study is that GAPDH physiologically binds to IP 3 R-delivering NADH in close proximity to the channel, thus regulating intracellular Ca 2ϩ signaling. This conclusion is supported by several key findings, including abolition of the GAPDH augmentation of Ca 2ϩ release by selective blockade of IP 3 R͞GAPDH binding. Locally generated NADH regulating IP 3 R is reminiscent of the scaffolding protein PSD95 linking neuronal nitric oxide synthase to the glutamate NMDA receptor for its nitrosylation and activation (12) . Perhaps other small signaling molecules, created by spatially targeted and effector-coupled enzymes, provide analogous local regulation.
Our initial study characterizing NADH stimulation of IP 3 Rmediated Ca 2ϩ release (8) focused on the pathophysiological augmentation of Ca 2ϩ release by hypoxia. The GAPDH͞IP 3 R complex appears perfectly positioned to facilitate cellular death in response to inhibition of oxidative respiration in the mitochondria. Increases in glycolysis due to inhibition of oxidative respiration (13) could augment GAPDH activity, sensitizing the IP 3 R for activation. Inhibition of oxidative respiration leads to mitochondrial depolarization and release of cytochrome c (11), which also sensitizes the IP 3 R for activation. These two processes may work coordinately in close proximity to mitochondria to increase cytosolic Ca 2ϩ during programmed cell death.
Our finding that GAPDH is physiologically bound to IP 3 R suggests that changes in the formation of NADH during normal alterations in cellular physiology may also regulate Ca 2ϩ signaling through IP 3 R (Fig. 3) . This concept is supported by numerous studies showing that alterations of glycolytic enzymes can impact cytosolic Ca 2ϩ levels (14 -16). Physiologic intracellular NADH levels are Ϸ1-10 M (7), whereas half-maximal augmentation of IP 3 R calcium release occurs at 50 M NADH. This result suggests that changes in GAPDH activity can modify local NADH levels within physiologically relevant ranges and likely regulate IP 3 R activity in response to the myriad of signals that occur during respiratory metabolism. Fig. 3 . GAPDH creates local NADH for IP3R regulation. This cartoon depicts a mechanism whereby GAPDH may regulate IP 3R Ca 2ϩ function. Because both the IP 3R and GAPDH both work as tetramers, we hypothesize that two noncatalytic GAPDH subunits bind through C150 to individual IP 3R subunits through C992 or C995. This complex leaves two catalytic subunits of GAPDH positioned in direct proximity with the IP 3R. The glycolysis-mediated activation of GAPDH causes increased local NADH, which, in the presence of IP 3, stimulates IP 3R activity. Released Ca 2ϩ may enter mitochondria to enhance oxidative respiration (physiological) or release cytochrome c (pathophysiological) (data not shown).
